Help Researchers Learn About Potential Treatments for ADPKD
If you or someone you love lives with autosomal dominant polycystic kidney disease (ADPKD), you know how urgently we need better treatments.
That’s why we’re sharing this opportunity with you. GSK is running a new clinical trial called the MAPLE study. It’s testing the safety and side effects of a new investigational drug. They’re looking for Canadians aged 25 to 65, living with ADPKD, to join the study at sites in Ontario and Quebec. Some other eligibility conditions apply.
To learn more and determine if you may be eligible, please contact your doctor.
We’re proud to support this opportunity for our community to get involved.
Not sure if the study is right for you? Talk to your doctor about your eligibility for the clinical trial. If you have questions about the study, post your questions on My PKD and we’ll get answers directly from the GSK study team.
